Tecan to present at UBS Global Life Sciences Conference
(Thomson Reuters ONE) -
Tecan Group AG /
Tecan to present at UBS Global Life Sciences Conference
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Männedorf, Switzerland, September 13, 2011 - The Tecan Group (SIX Swiss
Exchange: TECN) today announced that it will present at the UBS Global Life
Sciences Conference on Tuesday, September 20, 2011 in New York City.
The investor presentation will begin at 08:30 a.m. EDT (14:30 p.m. CET) and will
be webcast live. The webcast may be accessed under the "Investor Relations" tab
of Tecan's website www.tecan.com.
A replay of the webcast will be available shortly following the presentation and
will remain available for at least four weeks.
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and
solutions in biopharmaceuticals, forensics and clinical diagnostics. The company
specializes in the development, production and distribution of automated
workflow solutions for laboratories in the life sciences sector. Its clients
include pharmaceutical and biotechnology companies, university research
departments, forensic and diagnostic laboratories. As an original equipment
manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM
instruments and components that are then distributed by partner companies.
Founded in Switzerland in 1980, the company has manufacturing, research and
development sites in both Europe and North America and maintains a sales and
service network in 52 countries. In 2010, Tecan generated sales of CHF 371
million (USD 356 million; EUR 269 million). Registered shares of Tecan Group are
traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN: 12100191.
For further information:
Tecan Group
Martin Braendle
Head of Corporate Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor(at)tecan.com
www.tecan.com
--- End of Message ---
Tecan Group AG
Seestrasse 103 Männedorf Switzerland
ISIN: CH0012100191;
Press Release (PDF):
http://hugin.info/100384/R/1545722/474030.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Tecan Group AG via Thomson Reuters ONE
[HUG#1545722]
Unternehmensinformation / Kurzprofil:
Datum: 13.09.2011 - 14:00 Uhr
Sprache: Deutsch
News-ID 64385
Anzahl Zeichen: 3007
contact information:
Town:
Männedorf
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 170 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Tecan to present at UBS Global Life Sciences Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Tecan Group AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
